Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Bavarian Nordic

Monkeypox outbreak may boost the shares of these companies

As health authorities all over the globe search for ways to stop the monkeypox outbreak, investors are snapping up shares of companies that could benefit from the race to quell the disease.

Tribune News Service

In race for monkeypox vaccines, experts see repeat of COVID

Public health officials warn that moves by rich countries to buy large quantities of monkeypox vaccine could leave millions of people in Africa unprotected against a more dangerous version of the disease

The Independent UK

US signs off on 800,000 more doses of monkeypox vaccine

Health regulators say nearly 800,000 doses of monkeypox vaccine will soon be available for U.S. distribution

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

U.S., EU clear manufacturing plant for Bavarian Nordic's monkeypox vaccine

Drugmaker Bavarian Nordic said U.S. and European regulators have approved the use of Jynneos vaccine doses made at the company's plant in Denmark as global efforts to tackle the monkeypox outbreak pick up pace.

Reuters

Bavarian Nordic in talks to expand monkeypox vaccine output

Bavarian Nordic, the Danish company behind the vaccine being used to try to stem a global outbreak of monkeypox, is in talks to potentially expand production capacity, its CEO said on Monday.

Reuters

Bavarian Nordic monkeypox vaccine wins EU approval

Danish biotechnology company Bavarian Nordic said on Monday the European Commission had given permission for its Imvanex vaccine to be marketed as protection against monkeypox, as recommended last week by the European Medicines Agency (EMA).

Reuters

Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

EU drug regulator recommends clearing vaccine for monkeypox

The European Medicines Agency says the smallpox vaccine made by Bavarian Nordic should also be authorized against monkeypox as an outbreak of the once-rare disease sickens people across Europe

The Independent UK

The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

US regulators clear way for more monkeypox vaccine shipments

U.S. officials say thousands more doses of the monkeypox vaccine could soon begin shipping from Denmark

The Independent UK

The U.S. Government Had What It Needed To Prevent the Spread of Monkeypox. It Happened Anyway.

Foot-dragging and red tape by the CDC and the FDA have fueled an avoidable outbreak.

Reason

White House Outlines New Monkeypox Vaccine Strategy: What You Need To Know

The White House unveiled the first phase of its national monkeypox vaccine strategy, with plans to send doses to areas with confirmed outbreaks. The U.S. Department of Health and Human Services plans to distribute 296,000 doses of the Bavarian Nordic A/S's (OTC:BVNRY) Jynneos vaccine, an already-developed monkeypox vaccine. The U.S. is releasing 56,000 doses of…

Benzinga

EU regulator considers clearing smallpox shot for monkeypox

The European Medicines Agency says it will begin reviewing data to decide if a smallpox vaccine made by the pharmaceutical company Bavarian Nordic might also be authorized for monkeypox, amid a growing outbreak of the disease across the continent

The Independent UK

Monkeypox is not a global emergency for now, says WHO. 3 things we need to know next about how it's mutating and spreading

The World Health Organization (WHO) has decided not to declare monkeypox a public health emergency of international concern. This may change in the future.

The Conversation

Get all your
news in one place.

100’s of premium titles.
One news app.

Foreign Affairs

Monkeypox and the Perils of Vaccine Nationalism

Rich Countries and the WHO Must Heed the Lessons of COVID-19

Benzinga

EU, Bavarian Nordic Ink Supply Pact For 110,000 Monkeypox Vaccines

European Health Emergency Preparedness and Response Authority (HERA) has ordered 110,000 doses of Bavarian Nordic A/S's (OTC:BVNRY) MVA-BN smallpox/monkeypox vaccine. Deliveries of vaccines to HERA will commence immediately and be completed during the following months. The vaccines will be bought with EU funds and delivered to EU states, Reuters reported citing EU health commissioner Stella Kyriakides.…

Reuters

EU signs deal with Bavarian Nordic for delivery of monkeypox vaccine

The European Commission on Tuesday said it had signed a deal with Danish biotech firm Bavarian Nordic for the delivery of around 110,000 doses of monkeypox vaccine.

The Independent UK

US buys more monkeypox vaccine as global case count grows

The U.S. government is building up its supply of monkeypox vaccine to contend with escalating cases identified in a surprising international outbreak, health officials said Friday

Get all your
news in one place.

100’s of premium titles.
One news app.

Reuters

German vaccine authority recommends Imvanex for adults at risk of monkeypox

Germany's vaccine advisory committee recommends that people over 18 who have been exposed to or are at increased risk of monkeypox infection receive Bavarian Nordic's Imvanex vaccine, it said on Thursday.

Reuters

Bavarian Nordic eyes more monkeypox vaccine orders amid global "wake-up call"

Biotechnology company Bavarian Nordic expects to sign more contracts for its vaccine against monkeypox after "overwhelming" interest from governments around the world, its management told investors on Tuesday.

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

Wales Online

Expert confident we have vaccines and drugs to treat monkeypox

Treatments do exist for those who become quite ill from the virus

The Conversation

Monkeypox: we have vaccines and drugs to treat it

Medicines are not normally needed to treat monkeypox. The illness is usually mild and most people infected will recover within a few weeks without needing treatment. But there are vaccines that can be used to control monkeypox outbreaks, which some countries are already using. And treatments do exist for those…

Benzinga

Pharma Firm SIGA Cashes In On Monkeypox Scare

New York-based pharmaceutical firm SIGA Technologies (NASDAQ: SIGA) is among the companies to benefit from the growing threat of monkeypox, recently pushing its shares to an almost decade-high after the company obtained approval in Europe to use its TPOXX antiviral drug for the treatment of monkeypox.

Bangkok Post

Explainer: What vaccines, treatments do we have to combat monkeypox?

With cases of monkeypox inexplicably on the rise outside of Africa - where the viral disease is endemic - public health officials are using contact tracing, isolation and targeted vaccination to curb its spread.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.